IMMURON LTD IMRN
SPONSORED ADR · ADR · CUSIP 45254U101
Small biotech company
- SectorHealth care
- IndustryPharmaceutical Preparations
- Websiteimmuron.com.au
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $2.14.
Trends to Q2 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 6 |
| Q1 2020 | 6 |
| Q2 2020 | 5 |
| Q3 2020 | 8 |
| Q4 2020 | 6 |
| Q1 2021 | 8 |
| Q2 2021 | 6 |
| Q3 2021 | 6 |
| Q4 2021 | 8 |
| Q1 2022 | 9 |
| Q2 2022 | 5 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2020 | 4 | 2 |
| Q4 2020 | 1 | 3 |
| Q1 2021 | 3 | 1 |
| Q2 2021 | 1 | 4 |
| Q3 2021 | 1 | 2 |
| Q4 2021 | 2 | 2 |
| Q1 2022 | 3 | 5 |
| Q2 2022 | 0 | 6 |
Biggest buyers
| None |
Biggest sellers
| COURAGE CAPITAL MANAGEMENT LLC | Sold out | -66.6k |
| OLD MISSION CAPITAL LLC | Sold out | -12.3k |
| Tower Research Capital LLC (TRC) | Sold out | -3.0k |
| UBS Group AG | Sold out | -2.3k |
| MORGAN STANLEY | Reduced | -320 |
| BNP PARIBAS FINANCIAL MARKETS | Reduced | -249 |
Insider purchases and sales in Q2 2022
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2022.
Holders, Q2 2022
| Manager | Shares | Change |
|---|---|---|
| MORGAN STANLEY 0.00% of their portfolio | 4.6k $10.0k | Reduced -320 |
| Stephens Consulting, LLC 0.00% of their portfolio | 1.5k $3.2k | Unchanged |
| Global Wealth Management Investment Advisory, Inc. 0.00% of their portfolio | 100 $0 | Unchanged |
| BNP PARIBAS FINANCIAL MARKETS 0.00% of their portfolio | 51 $109 | Reduced -249 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |